Gary S. Jacob
33Patents
18h-index
23Co-inventors
81Inventor score
Filing activity: Dec 22, 1988 → Jun 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7041786B2 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | Emerging Cross-Sectional Technologies | 61 | Expired |
| US6491903B1 | Particles comprising amphiphilic copolymers | Emerging Cross-Sectional Technologies | 58 | Expired |
| US6225325A | Use of alkylated iminosugars to treat multidrug resistance | Human Necessities | 49 | Expired |
| US6610703B1 | Method for treatment of glycolipid storage diseases | Human Necessities | 36 | Expired |
| US5103008A | Compound, N-butyl-deoxynojirimycin-6-phosphate | Chemistry; Metallurgy | 35 | Expired |
| US7879802B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 35 | Active |
| US6696059B2 | Combination drug therapy for glycolipid storage diseases | Human Necessities | 34 | Expired |
| US5043273A | Phosphorylated glycosidase inhibitor prodrugs | Chemistry; Metallurgy | 34 | Expired |
| US7799897B2 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4957926A | Method of treating herpesviruses | Human Necessities | 33 | Expired |
| US8207295B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 31 | Active |
| US8114831B2 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | Emerging Cross-Sectional Technologies | 31 | Active |
| US8357775B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 31 | Active |
| US8716224B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 27 | Active |
| US6495570B2 | Combination drug therapy for glycolipid storage diseases | Human Necessities | 27 | Expired |
| US8497348B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 26 | Active |
| US8637451B2 | Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis | Emerging Cross-Sectional Technologies | 26 | Active |
| US6689759B1 | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy | Human Necessities | 18 | Expired |
| US8901075B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 15 | Active |
| US9266926B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 13 | Active |
| US9238677B2 | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders | Chemistry; Metallurgy | 12 | Active |
| US5776083A | Exercise device for use in the rehabilitative therapy of joint complexes | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7816560B1 | Long chain n-alkyl compounds and oxa-derivatives thereof | Emerging Cross-Sectional Technologies | 10 | Expired |
| US9089515B2 | Long chain N-alkyl compounds and oxa-derivatives thereof | Emerging Cross-Sectional Technologies | 9 | Active |
| US6809083B1 | Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections | Human Necessities | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.